Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data-driven insights into post-autopsy consultations: causes of perinatal mortality and parental outcomes.

Pathologica·2025
Same author

The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial.

Leukemia·2025
Same author

Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial.

Leukemia·2025
Same author

Medico-legal litigation in obstetrics and gynecology: an eleven-year case series and comparison of out-of-court resolution and legal proceedings.

European journal of obstetrics, gynecology, and reproductive biology·2025
Same author

Integrating Molecular Diagnostics into Cervical Cancer Screening: A Workflow Using FFPE Tissue Samples.

Current issues in molecular biology·2025
Same author

AntiCD44 antibody-conjugated gold nanoparticles for targeted photothermal therapy of endometriotic cells.

Biomaterials science·2025
Same journal

Predictive markers of endometriosis: a future perspective.

Archives of gynecology and obstetrics·2026
Same journal

Phototoxicity of brightfield live-cell imaging on murine ovarian follicles.

Archives of gynecology and obstetrics·2026
Same journal

First-trimester lipoprotein(a) and longitudinal renal biomarker trajectories preceding preeclampsia: a pilot cohort study.

Archives of gynecology and obstetrics·2026
Same journal

Correction: Intraoperative hemodynamics and anesthetic implications in superobese parturients undergoing cesarean delivery: a retrospective cohort analysis.

Archives of gynecology and obstetrics·2026
Same journal

Ophthalmic artery Doppler: reference values in low-risk pregnant women.

Archives of gynecology and obstetrics·2026
Same journal

Diagnostic and treatment delay in women with cancer in pregnancy: a case-based study.

Archives of gynecology and obstetrics·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Peripartum cardiomyopathy.

Melita Moioli1, Mario Valenzano Menada, Giorgio Bentivoglio

  • 1Department of Obstetrics and Gynaecology, San Martino Hospital, University of Genoa, Largo R. Benzi 1, 16132, Genoa, Italy. melitamoioli@libero.it

Archives of Gynecology and Obstetrics
|August 6, 2009
PubMed
Summary
This summary is machine-generated.

Peripartum cardiomyopathy (PPCM) is a rare heart condition affecting pregnant women. Early diagnosis and treatment are crucial for recovery and optimizing pregnancy outcomes.

More Related Videos

Noninvasive Electrocardiography in the Perinatal Mouse
04:36

Noninvasive Electrocardiography in the Perinatal Mouse

Published on: June 12, 2020

Related Experiment Videos

Last Updated: Jun 21, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Noninvasive Electrocardiography in the Perinatal Mouse
04:36

Noninvasive Electrocardiography in the Perinatal Mouse

Published on: June 12, 2020

Area of Science:

  • Cardiology
  • Obstetrics
  • Maternal-Fetal Medicine

Background:

  • Peripartum cardiomyopathy (PPCM) is a rare form of heart failure.
  • It is defined as left ventricular dysfunction occurring in the last month of pregnancy.
  • The incidence is estimated at 1 in 3,000-4,000 live births, with poorly understood pathogenesis.

Purpose of the Study:

  • To define peripartum cardiomyopathy (PPCM).
  • To outline diagnostic criteria and treatment strategies.
  • To discuss prognosis and recurrence risks.

Main Methods:

  • Diagnosis relies on clinical presentation of heart failure and objective evidence of left ventricular systolic dysfunction.
  • Treatment mirrors that for non-pregnant patients with systolic dysfunction.
  • Medical therapy includes digoxin, diuretics, sodium restriction, and afterload reducers.

Main Results:

  • Effective treatment improves outcomes, reducing mortality and increasing full recovery of left ventricular function.
  • Anticoagulation with heparin is recommended due to high thrombosis risk.
  • ACE inhibitors and ARBs are contraindicated during pregnancy due to neonatal risks.

Conclusions:

  • Early diagnosis and treatment are essential for optimizing pregnancy outcomes in PPCM.
  • Prognosis is poor for persistent cardiomyopathy.
  • Subsequent pregnancies carry a risk of recurrence.